[National economic consequences of vaccines].
Bergman
Annika
A
Institutet för hälso- och sjukvårdsekonomi, Lund. ab@ihe.se
Persson
Ulf
U
D001428:Bacterial Vaccines / Q000191:economics*; D002648:Child; D002675:Child, Preschool; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D007223:Infant; D008390:Markov Chains; D011008:Pneumococcal Infections / Q000191:economics / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000191:economics; D019057:Quality-Adjusted Life Years; D013548:Sweden; D014765:Viral Vaccines / Q000191:economics*
D001428:Bacterial Vaccines; D022242:Pneumococcal Vaccines; D014765:Viral Vaccines